Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clofutriben And Placebo Phase 2 Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

NCT07296484 is registered in ClinicalTrials.gov with Sparrow Pharmaceuticals as lead sponsor.

NCT NCT07296484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07296484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clofutriben And Placebo Phase 2 Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Lead sponsor
Sparrow Pharmaceuticals
Phase
Phase 2
Overall status
Recruiting
Start date
November 29, 2025
Completion date
June 30, 2028
Enrollment
1,500 (estimated)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

cortisol excess, type 2 diabetes